简化与完整MRI方案评估结直肠癌肝转移治疗反应的比较
本研究回顾性纳入2012年1月1日至2021年12月3日接受化疗且至少有一次钆塞酸增强MRI随访的结直肠癌肝转移连续患者,比较简化MRI与完整MRI评估治疗反应。7名放射科医生评估RECIST 1.1分类及新病灶,简化MRI与完整MRI的阅者内一致性为中等至相当(κ 0.63–0.89),阅者间一致性RECIST 1.1分类为相当(κ 0.71 vs 0.68),新病灶为中等(κ 0.56 vs 0.49)。作者认为简化MRI可能作为完整MRI的替代用于随访。
要点
- 简化MRI与完整MRI评估RECIST 1.1分类的阅者内一致性为相当(κ 0.66–0.89)。
- 简化MRI检测新病灶的阅者内一致性为相当(κ 0.63–0.81)。
- 简化MRI评估RECIST 1.1分类的阅者间一致性为相当(κ 0.71),新病灶为中等(κ 0.56)。
核心结论
- 简化MRI可能作为完整MRI的替代用于结直肠癌肝转移患者的随访。
研究设计与样本
- 回顾性研究纳入195例结直肠癌肝转移患者(平均年龄54.4±12.1岁,135例男性),每例随机选取基线和随访钆塞酸增强MRI各一次,随访MRI分为完整MRI和简化MRI两组图像;7名放射科医生间隔一个月先后评估两组图像,每名阅者分配80–91例患者,以Fleiss κ评估阅者间一致性。
诊断标准与关键数值
- 简化MRI与完整MRI的阅者内一致性:RECIST 1.1分类κ 0.66–0.89,新病灶检出κ 0.63–0.81;阅者间一致性:简化MRI评估RECIST 1.1分类κ 0.71(95%CI 0.65–0.78),完整MRI κ 0.68(95%CI 0.61–0.75);简化MRI评估新病灶κ 0.56(95%CI 0.41–0.69),完整MRI κ 0.49(95%CI 0.35–0.65)。
临床应用与阅片要点
- 简化MRI序列包括冠状位和轴位肝胆期成像、轴位扩散加权成像和冠状位T2加权成像;在随访评估治疗反应时,简化MRI的RECIST 1.1分类和新病灶检出与完整MRI的一致性分别为相当和中等。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To compare abbreviated magnetic resonance imaging (MRI) to complete MRI for treatment response assessment of colorectal liver metastases.
MATERIAL AND METHODS: This retrospective study included consecutive patients with colorectal liver metastases between January 1, 2012, and December 3, 2021, who were undergoing chemotherapy and who had at least one follow-up gadoxetic-enhanced MRI. For each patient, two MRIs (baseline MRI and follow-up MRI) were randomly selected. Follow-up MRIs were separated into two sets of images: complete MRIs, including all imaging sequences, and abbreviated MRIs, including coronal and axial hepatobiliary phase imaging, axial diffusion-weighted imaging, and coronal T2-weighted imaging. Seven radiologists reviewed the two sets of images, with a month's break in between, assessing Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 category and the presence of new lesions, with each reader assigned 80-91 patients. Inter-reader agreement was assessed using Fleiss' kappa (κ).
RESULTS: One-hundred ninety-five patients (mean age 54.4 +/- 12.1 years, 135 men) were evaluated. Intra-reader agreement between abbreviated and complete MRI was substantial for the RECIST 1.1 category (κ, 0.66-0.89) and the detection of new lesions (κ, 0.63-0.81). Inter-reader agreement was substantial for RECIST 1.1 category using abbreviated MRI and complete MRI (κ, 0.71 (95% CI: 0.65-0.78) and 0.68 (95% CI: 0.61-0.75)), and moderate for the presence of new lesions using abbreviated MRI and complete MRI (κ, 0.56 (95% CI: 0.41-0.69) and 0.49 (95% CI: 0.35-0.65)).
CONCLUSION: Abbreviated MRI may serve as an alternative to complete MRI for the follow-up of patients with colorectal liver metastases.
KEY POINTS: Question Abbreviated MRI is a time-saving and cost-effective exam, but only one study has compared it with complete MRI for treatment response assessment of colorectal liver metastases. Findings In our study, abbreviated follow-up MRI achieved substantial inter-reader agreement for the RECIST 1.1 category and moderate inter-reader agreement for the presence of new lesions. Clinical relevance Abbreviated liver MRIs are adequate substitutes for complete liver MRIs for colorectal liver metastases in the follow-up setting when the goal is to assess treatment response, resulting in shorter examination times and potential reductions in costs.
引用
- El Homsi M, Bou Ayache J, Fernandes MC, et al. Comparison of abbreviated and complete MRI protocols for treatment response assessment of colorectal liver metastases. Eur Radiol. 2024. PMID: 39658684. doi:10.1007/s00330-024-11277-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。